Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of TRanEXamic Acid in Reduction Mammoplasty (TREX-ARM): a Double-blinded Randomized Controlled Trial

NCT04947514 is registered in ClinicalTrials.gov with Montefiore Medical Center as lead sponsor.

NCT NCT04947514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04947514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of TRanEXamic Acid in Reduction Mammoplasty (TREX-ARM): a Double-blinded Randomized Controlled Trial
Lead sponsor
Montefiore Medical Center
Phase
Phase 4
Overall status
Completed
Start date
October 29, 2021
Completion date
July 13, 2022
Enrollment
98 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematoma postoperative, venous thromboembolism